BLIV vs LPSN

The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a strong Current Ratio of 24.19 and moderate gross margin of 48.98%, the company is deeply unprofitable with an operating margin of -1507.43% and ROE of -109.04%. Revenue has collapsed by 54.20% year-over-year, and valuation multiples like Price/Sales of 22.48 are extremely high for a shrinking, unprofitable business. The stock has underperformed over the long term despite a short-term 6M gain, and peer comparisons show similar distressed profiles with no clear catalysts.

LPSN exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -0.79, indicating negative shareholders' equity. Despite a high gross margin of 71.53%, the company is suffering from a systemic collapse in value, with a 5-year price decline of 99.7% and contracting year-over-year revenue of -19%. While recent earnings have beaten lowered analyst expectations, the fundamental health metrics and bearish insider activity suggest a high risk of insolvency or further massive dilution.